Phosphatidylinositol 4-kinase
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
'''Phosphatidylinositol 4-kinase''' (PI4K) modulates inter-organelle lipid tarfficking. phosphoinositide signalling and intracellular vescicle trafficking. The catalytic domain of PI4K is required for the synthesis of phosphatidylinositol 4-phosphate<ref>PMID:23608234</ref>. The mammalian PI4K are classified into 2 types - II and III - based on their molecular mass and modulation by detergent and adenosine.<br /> | '''Phosphatidylinositol 4-kinase''' (PI4K) modulates inter-organelle lipid tarfficking. phosphoinositide signalling and intracellular vescicle trafficking. The catalytic domain of PI4K is required for the synthesis of phosphatidylinositol 4-phosphate<ref>PMID:23608234</ref>. The mammalian PI4K are classified into 2 types - II and III - based on their molecular mass and modulation by detergent and adenosine.<br /> | ||
- | '''Phosphatidylinositol 4-kinase IIα''' accounts for the bulk of PI4K activity in the brain and is concentrated at synapses<ref>PMID:12646710</ref>.<br /> | + | *'''Phosphatidylinositol 4-kinase IIα''' accounts for the bulk of PI4K activity in the brain and is concentrated at synapses<ref>PMID:12646710</ref>.<br /> |
- | '''Phosphatidylinositol 4-kinase IIIβ''' is a key enzyme in the control of spingomyelin synthesis by controlling the flow of ceramide from the endoplasmic reticulum to the Golgi compartment<ref>PMID:17003043</ref>. | + | *'''Phosphatidylinositol 4-kinase IIIα''' catalyses the synthesis of phosphatidylinositol 4-phosphate in hepatitis C virus cells<ref>PMID:23675303</ref>. |
+ | *'''Phosphatidylinositol 4-kinase IIIβ''' is a key enzyme in the control of spingomyelin synthesis by controlling the flow of ceramide from the endoplasmic reticulum to the Golgi compartment<ref>PMID:17003043</ref>. | ||
== Relevance == | == Relevance == |
Revision as of 08:36, 21 July 2024
|
3D structures of phosphatidylinositol 4-kinase
Updated on 21-July-2024
References
- ↑ Clayton EL, Minogue S, Waugh MG. Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks. Prog Lipid Res. 2013 Jul;52(3):294-304. doi: 10.1016/j.plipres.2013.04.002. Epub , 2013 Apr 19. PMID:23608234 doi:http://dx.doi.org/10.1016/j.plipres.2013.04.002
- ↑ Guo J, Wenk MR, Pellegrini L, Onofri F, Benfenati F, De Camilli P. Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3995-4000. doi:, 10.1073/pnas.0230488100. Epub 2003 Mar 19. PMID:12646710 doi:http://dx.doi.org/10.1073/pnas.0230488100
- ↑ Reiss S, Harak C, Romero-Brey I, Radujkovic D, Klein R, Ruggieri A, Rebhan I, Bartenschlager R, Lohmann V. The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A. PLoS Pathog. 2013 May;9(5):e1003359. PMID:23675303 doi:10.1371/journal.ppat.1003359
- ↑ Toth B, Balla A, Ma H, Knight ZA, Shokat KM, Balla T. Phosphatidylinositol 4-kinase IIIbeta regulates the transport of ceramide between the endoplasmic reticulum and Golgi. J Biol Chem. 2006 Nov 24;281(47):36369-77. doi: 10.1074/jbc.M604935200. Epub 2006, Sep 26. PMID:17003043 doi:http://dx.doi.org/10.1074/jbc.M604935200
- ↑ Yang N, Ma P, Lang J, Zhang Y, Deng J, Ju X, Zhang G, Jiang C. Phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. J Biol Chem. 2012 Mar 9;287(11):8457-67. doi: 10.1074/jbc.M111.312561. Epub 2012 , Jan 17. PMID:22253445 doi:http://dx.doi.org/10.1074/jbc.M111.312561
- ↑ Mejdrova I, Chalupska D, Kogler M, Sala M, Plackova P, Baumlova A, Hrebabecky H, Prochazkova E, Dejmek M, Guillon R, Strunin D, Weber J, Lee G, Birkus G, Mertlikova-Kaiserova H, Boura E, Nencka R. Highly Selective Phosphatidylinositol 4-Kinase IIIbeta Inhibitors and Structural Insight into Their Mode of Action. J Med Chem. 2015 May 14;58(9):3767-93. doi: 10.1021/acs.jmedchem.5b00499. Epub, 2015 May 4. PMID:25897704 doi:http://dx.doi.org/10.1021/acs.jmedchem.5b00499